-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Sionna Therapeutics, Raises Price Target to $58

Benzinga·01/07/2026 11:46:11
语音播报
BTIG analyst Kambiz Yazdi maintains Sionna Therapeutics (NASDAQ:SION) with a Buy and raises the price target from $50 to $58.